As Asian markets navigate a landscape marked by cautious optimism amid dovish signals from global central banks, investors are increasingly turning their attention to smaller and potentially high-growth opportunities. Penny stocks, though an old term, remain a relevant area for those seeking hidden gems within the market. These stocks often represent smaller or newer companies that can offer significant growth potential when backed by strong financials. In this article, we will explore three such penny stocks in Asia that stand out for their robust balance sheets and promising long-term prospects.
Top 10 Penny Stocks In Asia
| Name | Share Price | Market Cap | Rewards & Risks |
| JBM (Healthcare) (SEHK:2161) | HK$2.81 | HK$2.3B | ✅ 3 ⚠️ 1 View Analysis > |
| Lever Style (SEHK:1346) | HK$1.51 | HK$933.97M | ✅ 4 ⚠️ 1 View Analysis > |
| TK Group (Holdings) (SEHK:2283) | HK$2.43 | HK$2.02B | ✅ 4 ⚠️ 1 View Analysis > |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD1.05 | SGD425.55M | ✅ 4 ⚠️ 1 View Analysis > |
| T.A.C. Consumer (SET:TACC) | THB4.94 | THB2.96B | ✅ 3 ⚠️ 3 View Analysis > |
| Atlantic Navigation Holdings (Singapore) (Catalist:5UL) | SGD0.096 | SGD50.26M | ✅ 2 ⚠️ 4 View Analysis > |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD3.40 | SGD13.38B | ✅ 5 ⚠️ 1 View Analysis > |
| F & J Prince Holdings (PSE:FJP) | ₱2.20 | ₱859.28M | ✅ 2 ⚠️ 3 View Analysis > |
| Livestock Improvement (NZSE:LIC) | NZ$1.00 | NZ$142.34M | ✅ 2 ⚠️ 5 View Analysis > |
| Scott Technology (NZSE:SCT) | NZ$2.91 | NZ$252.29M | ✅ 3 ⚠️ 1 View Analysis > |
Click here to see the full list of 959 stocks from our Asian Penny Stocks screener.
We'll examine a selection from our screener results.
Gunkul Engineering (SET:GUNKUL)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Gunkul Engineering Public Company Limited, with a market cap of THB16.60 billion, operates in the renewable energy sector by generating and selling energy in Thailand, Japan, and Vietnam.
Operations: The company's revenue is primarily derived from construction services (THB3.03 billion), generating and selling electricity (THB3.03 billion), and manufacturing and selling equipment for electrical systems (THB2.34 billion).
Market Cap: THB16.6B
Gunkul Engineering, a company in the renewable energy sector, has demonstrated significant earnings growth of 46.8% over the past year, outpacing its industry peers. Despite this growth and stable weekly volatility, Gunkul faces challenges with a high net debt to equity ratio of 88.7% and short-term assets that do not fully cover long-term liabilities. The board is experienced with an average tenure of 7.7 years, and shareholders have not been diluted recently. The company is expanding its footprint by establishing a holding company in the Philippines to enhance its renewable energy investments overseas.
- Jump into the full analysis health report here for a deeper understanding of Gunkul Engineering.
- Learn about Gunkul Engineering's future growth trajectory here.
STP&I (SET:STPI)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: STP&I Public Company Limited specializes in the fabrication of steel works and the manufacture and sale of boilers and pressure vessels, operating in Thailand, Japan, Spain, and internationally with a market cap of THB7.50 billion.
Operations: The company's revenue is primarily derived from Fabrication Work (THB1.67 billion), Sales and Services (THB1.01 billion), Rental of Real Estates (THB147 million), and Sales of Electricity and Services (THB415 million).
Market Cap: THB7.5B
STP&I has shown remarkable earnings growth, with a significant increase of 1833.4% over the past year, surpassing industry averages. The company reported a net income of THB 76.26 million for Q3 2025, reversing a loss from the previous year. Its short-term assets cover its short-term liabilities but fall short against long-term obligations. Despite high share price volatility and low return on equity at 4.1%, STP&I's debt is well covered by operating cash flow and interest payments are adequately managed by EBIT. With no recent shareholder dilution and seasoned management, it trades below estimated fair value.
- Click here to discover the nuances of STP&I with our detailed analytical financial health report.
- Assess STP&I's previous results with our detailed historical performance reports.
Q & M Dental Group (Singapore) (SGX:QC7)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Q & M Dental Group (Singapore) Limited is an investment holding company that offers private dental healthcare services across Singapore, Malaysia, China, and internationally with a market cap of S$486.44 million.
Operations: The company generates revenue primarily from its Core Dental Business, which accounts for S$176.77 million.
Market Cap: SGD486.44M
Q & M Dental Group (Singapore) has faced challenges with declining profit margins, currently at 4.9%, down from 8.6% last year, and a negative earnings growth of -44.2% over the past year. Despite this, its debt management is strong; the debt to equity ratio has improved to 62% over five years, and interest payments are well covered by EBIT at 4.6 times coverage. The company recently formed a joint venture for dental laboratory services with Aoxin Q & M Dental Group Limited's subsidiary, potentially enhancing its service offerings without immediate impact on net tangible assets or earnings per share for FY2025.
- Unlock comprehensive insights into our analysis of Q & M Dental Group (Singapore) stock in this financial health report.
- Review our growth performance report to gain insights into Q & M Dental Group (Singapore)'s future.
Key Takeaways
- Navigate through the entire inventory of 959 Asian Penny Stocks here.
- Searching for a Fresh Perspective? AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if STP&I might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com